| 000 | 03261nam a22003975i 4500 | ||
|---|---|---|---|
| 999 |
_c10620 _d10620 |
||
| 001 | 10620 | ||
| 003 | DE-He213 | ||
| 005 | 20210615040624.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180227s2018 si | s |||| 0|eng d | ||
| 020 | _a9789811076329 | ||
| 024 | 7 |
_a10.1007/978-981-10-7632-9 _2doi |
|
| 040 |
_aES-MaUEC _bspa _dES-VaUE |
||
| 050 | 4 |
_aRC632 .B43 _b2018 EB |
|
| 100 | 1 |
_aBhargava, Seema _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _0http://id.loc.gov/authorities/names/no2011137231 _0http://viaf.org/viaf/179340158 |
|
| 245 | 1 | 4 |
_aThe Clinical Application of Homocysteine _cby Seema Bhargava. |
| 264 | 1 |
_aSingapore _bSpringer Singapore : _bImprint: Springer _c2018. |
|
| 300 | _a1 recurso en línea (XIX, 96 páginas 19 ilustraciones a color) | ||
| 336 |
_2rdacontent _aTexto (visual) _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aMedicine (Springer-11650) | |
| 505 | 0 | _aIntroduction -- Discovery and metabolism -- Homocysteinemia and occlusive vascular disease -- Homocysteinemia and hypertension -- Homocysteinemia and its neurological effects -- Homocysteinemia in nephrology practice -- Homocysteinemia and oncology -- Homocysteinemia and otology -- Homocysteinemia and bones -- The body’s inherent defence against homocysteinemia -- Homocysteine and epigenetics -- Food fortification. | |
| 520 | 3 | _aThis book helps clinicians to optimally and appropriately utilize homocysteine levels in the diagnosis, prediction and management of and research into vascular disease and many other conditions. It also familiarizes readers with the pathophysiology and clinical implications of hyperhomocysteinemia. Laboratory investigations are gaining importance in the diagnosis and prognosis of patients, and as such, scientists and laboratorians are constantly attempting to identify new markers that will help in earlier diagnosis and better prognostication of conditions with high morbidity and mortality, as well as high prevalence. According to the WHO, developing countries are home to 80% of patients with coronary artery disease (CAD) and stroke – conditions with a mortality second only to cancer. Intensive research in these areas has resulted in the identification of homocysteine (declared the ‘marker of the millennium’) and several new markers for the diagnosis and prediction of CAD and stroke. The book is a valuable resource for clinicians and consultants in practice, as well as for postgraduate and undergraduate students of medicine, biotechnology and biochemistry. | |
| 988 | _aEBSPRINGER_2018 | ||
| 650 | 7 |
_9138639 _aBioquímica _2embne |
|
| 650 | 7 |
_aOncología _9139207 _2embne |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9789811076312 |
| 776 | 0 | 8 |
_iEdición impresa: _z9789811076336 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-7632-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 |
_db _feng _ggw _h0 |
||